Significance of selenium in thyroid physiology and pathology;Znaczenie selenu w fizjologii i patologii tarczycy

Polski Merkuriusz Lekarski

Volumn 38, Issue 228, 2015, Pages 348-353

  Lacka, Katarzyna ^a   Szeliga, Anna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

autoimmunity; selenium; thyroid

Indexed keywords

SELENIUM; THYROID HORMONE;

DEFICIENCY; HUMAN; METABOLISM; SECRETION (PROCESS); THYROID DISEASE; THYROID FUNCTION TEST; THYROID GLAND;

HUMANS; SELENIUM; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID GLAND; THYROID HORMONES;

EID: 84962396820     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Abalovich M, Llesuy S, Gutierrez S, et al. Peripheral parameters of oxidative stress in Graves' disease: the effects of methimazole and 131 iodine treatments. Clin Endocrinol (Oxf), 2003;59(3):321-7. ss.com.
2. Arnér ESJ, Holmgren A.: Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem, 2000; 267: 6102-6109. edpr
3. Balázs C, Kaczur V.: Effect of Selenium on HLA-DR Expression of Th t A t i Di 2012 2012 374635 s@
4. Bates JM, Spate VL, Morris JS, et al. Effects of selenium deficiency on tissue selenium content, deiodinase activity, and thyroid hormone economy in the rat during development. Endocrinology, 2000;141(7):2490-500. medpre
5. Beckett GJ, Arthur JR.: Selenium and endocrine systems. J Endocrinol, 2005;184(3):455-65.
6. Bhuyan AK, Sarma D, Saikia UK.: Selenium and the thyroid: A close-knit connection. Indian J Endocrinol Metab, 2012;16(Suppl 2):S354-5.
7. Bianco AC, Kim BW.: Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest, 2006;116(10):2571-9.
8. Conner TS, Richardson AC, Miller JC.: Optimal serum selenium concentrations are associated with lower depressive symptoms and negative mood among young adults. J Nutr, 2015;145(1):59-65.
9. Contempre B, Dumont JE, Denef JF, et al.: Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism. Eur J Endocrinol, 1995;133(1):99-109.
10. Contempre B, Dumont JE, Ngo B et al. Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium. J Clin Endocrinol Metab, 1991;73(1):213-5.
11. Contempre B, Le Moine O, Dumont JE, et al. Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor beta (TGF-beta). Mol Cell Endocrinol, 1996;124(1-2):7-15.
12. Corvilain B, Contempré B, Longombé AO, et al.: Selenium and the thyroid: how the relationship was established. Am J Clin Nutr, 1993;57(2 Suppl):244S-248S.
13. Derumeaux H, Valeix P, Castetbon K et al.: Association of selenium with thyroid volume and echostructure in 35-to 60-year-old French adults. Eur J Endocrinol, 2003;148(3):309-15.
14. Drutel A, Archambeaud F, Caron P.: Selenium and the thyroid gland: more good news for clinicians. Clin Endocrinol (Oxf), 2013;78(2):155-64.
15. Duntas LH, Benvenga S.: Selenium: an element for life. Endocrine, 2015; 48(3): 756-75.
16. Duntas LH.: Selenium and the thyroid: a close-knit connection. J Clin Endocrinol Metab, 2010;95(12):5180-8.
17. Duntas LH.: The role of selenium in thyroid autoimmunity and cancer. Thyroid, 2006;16(5):455-60.
18. Duntas LH, Mantzou E, Koutras DA.: Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol, 2003;148(4):389-93.
19. Ekholm R, Björkman U.: Glutathione peroxidase degrades intracellular hydrogen peroxide and thereby inhibits intracellular protein iodination in thyroid epithelium. Endocrinology, 1997;138(7):2871-8.
20. Gärtner R, Gasnier BC, Dietrich JW et al.: Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab, 2002;87(4):1687-91.
21. Gärtner R, Gasnier BC.: Selenium in the treatment of autoimmune thyroiditis. Biofactors, 2003;19(3-4):165-70.
22. Glattre E, Thomassen Y, Thoresen SO, et al.: Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol, 1989;18(1):45-9.
23. Harisa GI.: Oxidative stress and paraoxonase activity in experimental selenosis: effects of betaine administration. Biol Trace Elem Res, 2013;152(2):258-66.
24. Holben DH, Smith AM.: The diverse role of selenium within selenoproteins: a review. J Am Diet Assoc, 1999;99(7):836-43.
25. Jonklaas J, Danielsen M, Wang H.: A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer. Thyroid, 2013;23(9):1079-86.
26. Kaprara A, Krassas GE.: Selenium and thyroidal function; the role of immunoassays. Hell J Nucl Med, 2006; 9(3):195-203.
27. Kato MA, Finley DJ, Lubitz CC, et al.: Selenium decreases thyroid cancer cell growth by increasing expression of GADD153 and GADD34. Nutr Cancer, 2010;62(1):66-73.
28. Kieliszek M, Błażejak S.: Selenium: Significance, and outlook for supplementation. Nutrition, 2013;29(5):713-8.
29. Köhrle J, Jakob F, Contempré B, et al.: Selenium, the thyroid, and the endocrine system. Endocr Rev, 2005;26(7):944-84.
30. Komosinska-Vassev K, Olczyk K, Kucharz EJ, et al.: Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin Chim Acta, 2000;300 (1-2):107-17.
31. Kryukov GV, Castellano S, Novoselov SV, et al.: Characterization of mammalian selenoproteomes. Science, 2003;300(5624):1439-43.
32. Kucharzewski M, Braziewicz J, Majewska U, et al.: Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases. Biol Trace Elem Res, 2002;88(1):25-30.
33. Kvícala J, Havelka J, Nemec J, et al.: Selenium and rubidium changes in subjects with pathologically altered thyroid. Biol Trace Elem Res, 1992;32:253-8.
34. Lyons G, Stangoulis J, Graham R.: High-selenium wheat: biofortification for better health. Nutr Res Rev, 2003;16(1):45-60.
35. Marcocci C, Kahaly GJ, Krassas GE, et al.: European Group on Graves' Orbitopathy. Selenium and the course of mild Graves' orbitopathy. N Engl J Med, 2011; 19;364(20):1920-31.
36. Marcocci C, Vitti P, Cetani F et al. Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab, 1991;72(1):209-13.
37. Mazokopakis EE, Papadakis JA, Papadomanolaki MG, et al.: Effects of 12 months treatment with L-selenomethionine on serum anti-TPO Levels in Patients with Hashimoto's thyroiditis. Thyroid, 2007; 17(7):609-12.
38. Morris JS, Crane SB.: Selenium toxicity from a misformulated dietary supplement, adverse health effects, and the temporal response in the nail biologic monitor. Nutrients. 2013;5(4):1024-57.
39. Negro R.: Selenium and thyroid autoimmunity. Biologics, 2008; 2(2):265-73.
40. O'Grady TJ, Kitahara CM, DiRienzo AG, et al.: The association between selenium and other micronutrients and thyroid cancer incidence in the NIH-AARP Diet and Health Study. PLoS One, 2014;9(10):e110886.
41. Rayman MP.: Selenium and human health. Lancet, 2012; 379(9822):1256-68.
42. Rayman MP.: The importance of selenium to human health. Lancet, 2000; 356(9225):233-41.
43. Rayman MP.: The use of high-selenium yeast to raise selenium status: how does it measure up? Br J Nutr, 2004;92(4):557-73.
44. Salvatore D, Tu H, Harney JW, et al.: Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J Clin Invest, 1996;98(4):962-8.
45. Smyth PP.: Role of iodine in antioxidant defence in thyroid and breast disease. Biofactors, 2003;19(3-4):121-30.
46. Vitti P, Rago T, Mancusi F, et al.: Thyroid hypoechogenic pattern at ultrasonography as a tool for predicting recurrence of hyperthyroidism after medical treatment in patients withGraves' disease. Acta Endocrinol (Copenh), 1992;126(2):128-31.
47. Vrca VB, Skreb F, Cepelak I, et al.: Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium. Clin Chim Acta, 2004; 341 (1-2):55-63.
48. Wertenbruch T, Willenberg HS, Sagert C, et al.: Serum selenium levels in patients with remission and relapse of graves' disease. Med Chem. 2007;3(3):281-4.
49. Zhao SJ, Sun FJ, Tian EJ, et al.: The effects of iodine/selenium on the function of antigen presentation of peritoneal macrophages in rats. Zhonghua Yu Fang Yi Xue Za Zhi, 2008; 42(7):485-8.